Charles A. Reinhart III's Net Worth
$1.91 Million
Who is Charles A. Reinhart III?
Charles A. Reinhart III has an estimated net worth of $1.91 Million. This is based on reported shares across multiple companies, which include Pacira BioSciences, Inc., PHARMATHENE, INC, and OSIRIS THERAPEUTICS, INC..
SEC CIK
Charles A. Reinhart III's CIK is 0001470871
Past Insider Trading and Trends
2010 was Charles A. Reinhart III's most active year for acquiring shares with 2 total transactions. Charles A. Reinhart III's most active month to acquire stocks was the month of May. 2023 was Charles A. Reinhart III's most active year for disposing of shares, totalling 2 transactions. Charles A. Reinhart III's most active month to dispose stocks was the month of May. 2010 saw Charles A. Reinhart III paying a total of $0.00 for 125,000 shares, this is the most they've acquired in one year. In 2021 Charles A. Reinhart III cashed out on 2,648 shares for a total of $161,625.98, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PHARMATHENE, INC (ALT) Snapshot price: $9.91
SVP, Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Pacira BioSciences, Inc. (PCRX) Snapshot price: $31.775
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +26.77% | 9K |
—
|
—
| 42.63K |
Jun 14
| |||
Form 4
| -7.20% | -2.61K |
$38.40 | -$100,105.79 | 33.63K |
Jun 6 - Jun 7
| |||
Form 4
| +17.64% | 5.43K |
$61.37 | -$154,416.98 | 36.23K |
Jun 6 - Jun 8
| |||
Form 4
| +24.19% | 6K |
—
|
—
| 30.8K |
Jun 9
| |||
Form 4
| -9.65% | -2.65K |
$61.04 | -$161,625.98 | 24.8K |
Jun 4
| |||
Form 4
| +84.87% | 12.6K |
—
|
—
| 27.45K |
Jun 9
| |||
Form 4
| -9.11% | -1.49K |
$46.33 | -$68,986.86 | 14.85K |
Jun 4
| |||
Form 4
| +25.26% | 3.29K |
$42.91 | -$47,458.46 | 16.34K |
Jun 4 - Jun 5
| |||
Form 4
| +62.17% | 5K |
—
|
—
| 13.04K |
Jun 13
| |||
Form 4
| -8.09% | -708.00 |
$33.02 | -$23,378.16 | 8.04K |
Jun 4
| |||
Form 4
|
∞
| 8.75K |
—
|
—
| 8.75K |
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OSIRIS THERAPEUTICS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||